Literature DB >> 26432043

Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer.

Yu Jung Kim1, Mark F Munsell2, Ji Chan Park3, Larissa A Meyer4, Charlotte C Sun4, Alaina J Brown4, Diane C Bodurka4, Janet L Williams5, Dana M Chase6, Eduardo Bruera5, Lois M Ramondetta7.   

Abstract

OBJECTIVE: The objective of this study was to delineate and measure the symptom distress experienced by patients with advanced cervical cancer at the time of palliative care (PC) referral.
METHODS: A total of 156 patients with advanced cervical cancer were referred to PC from 2010 to 2012. Of these, 88 patients had completed the Edmonton Symptom Assessment System (ESAS) and were included in the analysis.
RESULTS: The mean age was 45years (25-76), 47% were white, 18% were African American, and 33% were Hispanic. Fifty-one percent were married, 64% had no advance directives, and 75% had recurrent disease. Clinically significant symptoms recorded by patient reported outcome measurement (defined as ESAS scores ≥4) were pain (81%), anorexia (72%), a poor feeling of well-being (70%), fatigue (69%), and insomnia (54%). The chief complaint recorded for the visit was pain in 94% of patients. According to the PC specialists' assessment, pain (96%), emotional distress (77%), and constipation (50%) were predominant symptoms. Various PC interventions including opioids, laxatives, and expressive supportive counseling were provided. Clinically significant symptoms including nausea, depression, anxiety, and feeling of well-being were significantly improved at follow-up visits.
CONCLUSION: More than half of patients with advanced cervical cancer were significantly burdened with pain, anorexia, a poor feeling of well-being, fatigue, insomnia, and constipation at the time of PC referral. This research is an integral step towards developing a standardized tool for assessing symptoms in women diagnosed with cervical cancer and thus maximizing effectiveness of patient centered care. Published by Elsevier Inc.

Entities:  

Keywords:  Advanced cervical cancer; Palliative care intervention; Symptom

Mesh:

Year:  2015        PMID: 26432043      PMCID: PMC8765286          DOI: 10.1016/j.ygyno.2015.09.079

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  36 in total

1.  The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients.

Authors:  Sriram Yennurajalingam; Bradley Atkinson; Jessica Masterson; David Hui; Diana Urbauer; Shi-Ming Tu; Eduardo Bruera
Journal:  J Palliat Med       Date:  2011-12-05       Impact factor: 2.947

Review 2.  Locally advanced cervical cancer: what is the standard of care?

Authors:  Zeina Al-Mansour; Claire Verschraegen
Journal:  Curr Opin Oncol       Date:  2010-09       Impact factor: 3.645

Review 3.  Symptom research in gynecologic oncology: a review of available measurement tools.

Authors:  Sonika Agarwal; Diane C Bodurka
Journal:  Gynecol Oncol       Date:  2010-08-04       Impact factor: 5.482

4.  Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study.

Authors:  Gabriella Ferrandina; Giovanna Mantegna; Marco Petrillo; Gilda Fuoco; Laura Venditti; Serena Terzano; Cristina Moruzzi; Domenica Lorusso; Andrea Marcellusi; Giovanni Scambia
Journal:  Gynecol Oncol       Date:  2011-10-27       Impact factor: 5.482

5.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

6.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

7.  Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic.

Authors:  Sriram Yennurajalingam; Diana L Urbauer; Katie L B Casper; Cielito C Reyes-Gibby; Ray Chacko; Valerie Poulter; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2010-08-24       Impact factor: 3.612

8.  The Memorial Delirium Assessment Scale.

Authors:  W Breitbart; B Rosenfeld; A Roth; M J Smith; K Cohen; S Passik
Journal:  J Pain Symptom Manage       Date:  1997-03       Impact factor: 3.612

9.  Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials.

Authors:  Kathryn Osann; Susie Hsieh; Edward L Nelson; Bradley J Monk; Dana Chase; David Cella; Lari Wenzel
Journal:  Gynecol Oncol       Date:  2014-09-03       Impact factor: 5.482

10.  Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients.

Authors:  Wadih Rhondali; Sriram Yennurajalingam; Jeanette Ferrer; Gary Chisholm; Marilene Filbet; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2013-11-16       Impact factor: 3.603

View more
  13 in total

1.  Innervation of cervical carcinoma is mediated by cancer-derived exosomes.

Authors:  Christopher T Lucido; Emily Wynja; Marianna Madeo; Caitlin S Williamson; Lauren E Schwartz; Brittney A Imblum; Ronny Drapkin; Paola D Vermeer
Journal:  Gynecol Oncol       Date:  2019-04-17       Impact factor: 5.482

Review 2.  A Brief Overview of Oncogenes and Signal Transduction Pathways in Gynecological Cancer.

Authors:  Emmanuel N Kontomanolis; Antonios Koutras; Zacharias Fasoulakis; Athanasios Syllaios; Michail Diakosavvas; Kyveli Angelou; Panagiotis Symeonidis; Athina A Samara; Vasilios Pergialiotis; Nikolaos Garmpis; Dimitrios Schizas; Athanasios Pagkalos; Athanasios Chionis; Georgios Daskalakis; Thomas Ntounis
Journal:  Cancer Diagn Progn       Date:  2022-03-03

3.  Two cases showing the effects of bevacizumab on recurrent cervical cancer with pleural effusion.

Authors:  Natsuko Kamiya; Tatsuya Matsunaga; Etsuko Miyagi
Journal:  Int Cancer Conf J       Date:  2022-03-16

4.  Associations Among Sleep Latency, Subjective Pain, and Thermal Pain Sensitivity in Gynecologic Cancer.

Authors:  Janae L Kirsch; Michael E Robinson; Christina S McCrae; Elizabeth L Kacel; Shan S Wong; Seema Patidar; Timothy S Sannes; Stephanie Garey; Jacqueline C Castagno; Deidre B Pereira
Journal:  Pain Med       Date:  2020-01-01       Impact factor: 3.750

5.  Accuracy and dosimetric parameters comparison of 3D-printed non-coplanar template-assisted computed tomography-guided iodine-125 seed ablative brachytherapy in pelvic lateral recurrence of gynecological carcinomas.

Authors:  Ang Qu; Ping Jiang; Shuhua Wei; Yuliang Jiang; Zhe Ji; Haitao Sun; Weiyan Li; Yuxia Shao; Jinghong Fan; Junjie Wang
Journal:  J Contemp Brachytherapy       Date:  2021-02-18

6.  MR guided high intensity focused ultrasound (MRgHIFU) for treating recurrent gynaecological tumours: a pilot feasibility study.

Authors:  Sharon L Giles; Georgios Imseeh; Ian Rivens; Gail R Ter Haar; Alexandra Taylor; Nandita M deSouza
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

7.  Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation.

Authors:  Jessica L Conway; Shira Felder; Jiayin Tang; Jelena Lukovic; Kathy Han; Zhihui Liu; Michael Milosevic; Anthony Fyles; Jennifer Croke
Journal:  Clin Transl Radiat Oncol       Date:  2020-04-16

8.  Diagnostic value of heat shock protein 90α and squamous cell carcinoma antigen in detection of cervical cancer.

Authors:  Songtao Han; Zhenzhen Cheng; Xiaoqun Zhao; Yanchun Huang
Journal:  J Int Med Res       Date:  2019-08-20       Impact factor: 1.671

9.  Health Care Access Measures and Palliative Care Use by Race/Ethnicity among Metastatic Gynecological Cancer Patients in the United States.

Authors:  Jessica Y Islam; Veeral Saraiya; Rebecca A Previs; Tomi Akinyemiju
Journal:  Int J Environ Res Public Health       Date:  2021-06-04       Impact factor: 3.390

10.  CT-guided 125I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy.

Authors:  Lina Tong; Ping Liu; Bin Huo; Zhi Guo; Hong Ni
Journal:  Onco Targets Ther       Date:  2017-08-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.